# deferasirox

NDC: 68462-494
Generic name: deferasirox
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20200106

FDA application: ANDA209433

## Active ingredients

- DEFERASIROX: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-494"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-494
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c